{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:00:44Z","timestamp":1790744444212,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Surg"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Accurate preoperative localization of parathyroid adenomas is essential to enable targeted and minimally invasive surgery in patients with primary hyperparathyroidism (pHPT). A variety of imaging techniques are available for this purpose. In routine clinical practice, cervical ultrasound (US) combined with scintigraphy is most commonly used as the initial diagnostic approach. However, the optimal strategy or combination of imaging modalities for reliable localization prior to surgery and its relevance for postoperative outcomes remains a matter of ongoing discussion. The aim of this study was therefore to evaluate the diagnostic performance of different preoperative imaging modalities and their combinations for the detection and localization of parathyroid pathology in a large cohort of patients treated at a specialized thyroid center. This study investigated how well the values reported under controlled study conditions translate to clinical practice and real-world application.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study included 325 patients who underwent minimally invasive parathyroidectomy for primary hyperparathyroidism between January 2015 and December 2023. All patients were evaluated with respect to the preoperative imaging modalities used for localization of the pathological parathyroid gland. In most cases, the standard diagnostic approach consisting of cervical US and scintigraphy was performed initially. When these examinations did not provide conclusive localization, additional imaging techniques were applied, including magnetic resonance imaging (MRI), computed tomography (CT), or 18-fluorocholine PET-CT (18-F PET-CT). In selected cases, invasive selective venous blood sampling (SVS) was also performed.<\/jats:p>\n                    <jats:p>The diagnostic performance of the different imaging modalities was assessed with regard to correct preoperative localization of the adenoma. Furthermore, the influence of factors such as concomitant thyroid disease, previous thyroid or parathyroid surgery, adenoma size and weight, as well as biochemical parameters including calcium and parathyroid hormone levels before, during, and after surgery was analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The primary endpoint of postoperative normalization of parathyroid hormone levels after minimally invasive parathyroidectomy was achieved in 94.2% of patients undergoing surgery. The combination of US and scintigraphy as the primary examination procedures was able to provide clear information regarding the localization of the adenoma in 51% of cases, in all other cases one or more additional imaging procedure had to be performed. On average, three examination modalities (triple localization methods) had to be performed per patient (IQR 2.00 - 3.00), with MRI as the most common supplemented procedure, so that in the end a median of two examinations (IQR 1.00 - 3.00) consistently indicated the correct localization. Related to the individual method, US had the highest over-all sensitivity (69.4%) of the imaging procedures. Scintigraphy and SPECT-CT had a similarly high sensitivity of 58.0% for scintigraphy and 56.4% for SPECT-CT. MRI still achieved a sensitivity of 52.9%, CT 36.6%, 18-fluocholine PET-CT 100% and selective venous blood sampling only 60%. The values in clinical practice and broader real-world application with exception of 18-fluocholine PET-CT were below those reported under controlled study conditions.<\/jats:p>\n                    <jats:p>US, scintigraphy, SPECT-CT and MRI each showed a decrease in the sensitivity of correct preoperative localization in the presence of simultaneous thyroid disease. Selective venous blood sampling showed a drop in sensitivity from 80% without prior surgery to 28.6% with prior thyroid or parathyroid surgery.<\/jats:p>\n                    <jats:p>\n                      The mean values of correctly selected parathyroid adenomas suggested that larger and more heavy parathyroid adenomas were more likely to be recognized. It was shown that parathyroid adenomas examined by US, scintigraphy, SPECT-CT and additional MRI had a significantly lower volume (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.004) and weight (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.045) than those examined by US and scintigraphy alone.\n                    <\/jats:p>\n                    <jats:p>\n                      The possibility of successful preoperative localization did not depend on the specific parathyroid hormone level. In contrast, it was shown that higher preoperative calcium levels do not necessarily correlate with easier imaging detection, but lower calcium levels are more often associated with greater diagnostic effort. In contrast, preoperatively determined parathyroid hormone correlated moderately with adenoma weight (\n                      <jats:italic>r<\/jats:italic>\n                      = 0.44;\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001) and adenoma volume (\n                      <jats:italic>r<\/jats:italic>\n                      = 0.17,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.024), whereas calcium showed only weak, albeit significant, correlations with adenoma weight (\n                      <jats:italic>r<\/jats:italic>\n                      = 0.20;\n                      <jats:italic>p<\/jats:italic>\n                      = 0.005) and volume (\n                      <jats:italic>r<\/jats:italic>\n                      = 0.17;\n                      <jats:italic>p<\/jats:italic>\n                      = 0.024).\n                    <\/jats:p>\n                    <jats:p>\n                      Without concomitant thyroid disease, the US determined volume correlated very strongly with the histopathologically determined volume with a Spearman correlation coefficient of 0.702 (\n                      <jats:italic>p<\/jats:italic>\n                      &lt;.001). With concomitant thyroid disease, the Spearman correlation coefficient decreased to 0.60 (\n                      <jats:italic>p<\/jats:italic>\n                      &lt;.001), although there was still a strong correlation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The findings of this study indicate that the combination of cervical ultrasound and scintigraphy remains an effective first-line imaging strategy for the localization of parathyroid adenomas in the majority of patients undergoing surgery for primary hyperparathyroidism in routine clinical practice. This approach was associated with a high success rate of minimally invasive parathyroidectomy in a specialized thyroid center. Nevertheless, a considerable proportion of patients required additional imaging modalities to achieve reliable preoperative localization, with MRI representing the most frequently used supplementary technique.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12893-026-03768-5","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T05:35:22Z","timestamp":1779773722000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Preoperative imaging strategies to optimize surgical treatment in primary hyperparathyroidism (pHPT)"],"prefix":"10.1186","volume":"26","author":[{"given":"Felicitas","family":"Fries","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Thaeren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Greschus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugen","family":"Muschler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Palmedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haug-Lambert","family":"Loriz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Cerasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"T\u00fcrler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Klozoris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen","family":"Kristiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wilhelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"issue":"12","key":"3768_CR1","doi-asserted-by":"publisher","first-page":"E200","DOI":"10.1002\/hed.24068","volume":"37","author":"J Daruwalla","year":"2015","unstructured":"Daruwalla J, Sachithanandan N, Andrews D, Miller JA. Ectopic intravagal parathyroid adenoma. Head Neck. 2015;37(12):E200\u20134.","journal-title":"Head Neck"},{"issue":"3","key":"3768_CR2","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.rxeng.2023.04.006","volume":"66","author":"A Adarve Castro","year":"2024","unstructured":"Adarve Castro A, Dom\u00ednguez Pinos D, Soria Utrilla V, O\u2019Farrell Del Campo JA, Sendra Portero F, Ruiz-G\u00f3mez MJ. Update in imaging tests used for the localization of parathyroid pathology. Radiologia (Engl Ed). 2024;66(3):236\u201347.","journal-title":"Radiologia (Engl Ed)"},{"issue":"2","key":"3768_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrendo.2017.104","volume":"14","author":"MD Walker","year":"2018","unstructured":"Walker MD, Silverberg SJ. Primary hyperparathyroidism. Nat Rev Endocrinol. 2018;14(2):115\u201325.","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"3768_CR4","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1053\/j.semnuclmed.2023.02.004","volume":"53","author":"MN Lalonde","year":"2023","unstructured":"Lalonde MN, Correia RD, Sykiotis GP, Schaefer N, Matter M, Prior JO. Parathyroid Imaging. Semin Nucl Med. 2023;53(4):490\u2013502.","journal-title":"Semin Nucl Med"},{"issue":"4","key":"3768_CR5","doi-asserted-by":"publisher","first-page":"256","DOI":"10.5114\/reum\/170705","volume":"61","author":"M Kochman","year":"2023","unstructured":"Kochman M. Primary hyperparathyroidism: clinical manifestations, diagnosis and evaluation according to the Fifth International Workshop guidelines. Reumatologia. 2023;61(4):256\u201363.","journal-title":"Reumatologia"},{"issue":"10","key":"3768_CR6","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.1210\/jc.2014-1415","volume":"99","author":"SJ Silverberg","year":"2014","unstructured":"Silverberg SJ, Clarke BL, Peacock M, Bandeira F, Boutroy S, Cusano NE, et al. Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99(10):3580\u201394.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"3768_CR7","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1210\/jc.2007-0219","volume":"92","author":"E Ambrogini","year":"2007","unstructured":"Ambrogini E, Cetani F, Cianferotti L, Vignali E, Banti C, Viccica G, et al. Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab. 2007;92(8):3114\u201321.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"3768_CR8","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00268-008-9509-9","volume":"32","author":"R Mihai","year":"2008","unstructured":"Mihai R, Sadler GP. Pasieka\u2019s parathyroid symptoms scores correlate with SF-36 scores in patients undergoing surgery for primary hyperparathyroidism. World J Surg. 2008;32(5):807\u201314.","journal-title":"World J Surg"},{"issue":"9","key":"3768_CR9","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1001\/archsurg.137.9.1022","volume":"137","author":"DG Sheldon","year":"2002","unstructured":"Sheldon DG, Lee FT, Neil NJ, Ryan JA. Jr. Surgical treatment of hyperparathyroidism improves health-related quality of life. Arch Surg. 2002;137(9):1022\u20136. discussion 6\u20138.","journal-title":"Arch Surg"},{"key":"3768_CR10","doi-asserted-by":"publisher","first-page":"760419","DOI":"10.3389\/fendo.2021.760419","volume":"12","author":"MA Morris","year":"2021","unstructured":"Morris MA, Saboury B, Ahlman M, Malayeri AA, Jones EC, Chen CC, et al. Parathyroid Imaging: Past, Present, and Future. Front Endocrinol (Lausanne). 2021;12:760419.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3768_CR11","doi-asserted-by":"crossref","unstructured":"Peixoto PPL, Dur\u00e7o D, Conti de Freitas LC. Primary hyperparathyroidism caused by a tiny mediastinal parathyroid adenoma with non localising imaging studies. BMJ Case Rep. 2024;17(7):e258728.","DOI":"10.1136\/bcr-2023-258728"},{"issue":"10","key":"3768_CR12","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","volume":"151","author":"SM Wilhelm","year":"2016","unstructured":"Wilhelm SM, Wang TS, Ruan DT, Lee JA, Asa SL, Duh Q-Y, et al. The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. JAMA Surg. 2016;151(10):959\u201368.","journal-title":"JAMA Surg"},{"issue":"1","key":"3768_CR13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/jama.2024.21972","volume":"333","author":"World Medical Association Declaration of Helsinki","year":"2025","unstructured":"World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Participants. JAMA. 2025;333(1):71\u20134.","journal-title":"JAMA"},{"issue":"7","key":"3768_CR14","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/BF03347996","volume":"20","author":"P Miccoli","year":"1997","unstructured":"Miccoli P, Pinchera A, Cecchini G, Conte M, Bendinelli C, Vignali E, et al. Minimally invasive, video-assisted parathyroid surgery for primary hyperparathyroidism. J Endocrinol Invest. 1997;20(7):429\u201330.","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"3768_CR15","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/S0002-9610(99)00054-9","volume":"177","author":"R Bellantone","year":"1999","unstructured":"Bellantone R, Lombardi CP, Raffaelli M, Rubino F, Boscherini M, Perilli W. Minimally invasive, totally gasless video-assisted thyroid lobectomy. Am J Surg. 1999;177(4):342\u20133.","journal-title":"Am J Surg"},{"issue":"11","key":"3768_CR16","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/BF03343657","volume":"22","author":"P Miccoli","year":"1999","unstructured":"Miccoli P, Berti P, Conte M, Bendinelli C, Marcocci C. Minimally invasive surgery for thyroid small nodules: preliminary report. J Endocrinol Invest. 1999;22(11):849\u201351.","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"3768_CR17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1308\/rcsann.2018.0158","volume":"101","author":"S Scattergood","year":"2019","unstructured":"Scattergood S, Marsden M, Kyrimi E, Ishii H, Doddi S, Sinha P. Combined ultrasound and Sestamibi scintigraphy provides accurate preoperative localisation for patients with primary hyperparathyroidism. Annals Royal Coll Surg Engl. 2019;101(2):97\u2013102.","journal-title":"Annals Royal Coll Surg Engl"},{"issue":"12","key":"3768_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00268-016-3621-z","volume":"40","author":"PY Sun","year":"2016","unstructured":"Sun PY, Thompson SM, Andrews JC, Wermers RA, McKenzie TJ, Richards ML, et al. Selective Parathyroid Hormone Venous Sampling in Patients with Persistent or Recurrent Primary Hyperparathyroidism and Negative, Equivocal or Discordant Noninvasive Imaging. World J Surg. 2016;40(12):1.","journal-title":"World J Surg"},{"issue":"1","key":"3768_CR19","doi-asserted-by":"publisher","first-page":"W82","DOI":"10.2214\/AJR.07.3002","volume":"190","author":"O Buckley","year":"2008","unstructured":"Buckley O, Halpenny D, Torreggiani WC. Role of the radiologist in the preoperative evaluation of primary hyperparathyroidism. AJR Am J Roentgenol. 2008;190(1):W82. author reply W3.","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"3768_CR20","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s13304-021-01213-1","volume":"74","author":"GL Canu","year":"2022","unstructured":"Canu GL, Cappellacci F, Noordzij JP, Piras S, Erdas E, Cal\u00f2 PG, et al. A mini-invasive approach is feasible in patients with primary hyperparathyroidism and discordant or negative localisation studies. Updates Surg. 2022;74(2):747\u201355.","journal-title":"Updates Surg"},{"issue":"2","key":"3768_CR21","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1245\/s10434-011-1870-5","volume":"19","author":"K Cheung","year":"2012","unstructured":"Cheung K, Wang TS, Farrokhyar F, Roman SA, Sosa JA. A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism. Ann Surg Oncol. 2012;19(2):577\u201383.","journal-title":"Ann Surg Oncol"},{"key":"3768_CR22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ijsu.2015.11.045","volume":"25","author":"F Medas","year":"2016","unstructured":"Medas F, Erdas E, Longheu A, Gordini L, Pisano G, Nicolosi A, et al. Retrospective evaluation of the pre- and postoperative factors influencing the sensitivity of localization studies in primary hyperparathyroidism. Int J Surg. 2016;25:82\u20137.","journal-title":"Int J Surg"},{"issue":"9","key":"3768_CR23","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1007\/s00259-021-05334-y","volume":"48","author":"P Petranovi\u0107 Ov\u010dari\u010dek","year":"2021","unstructured":"Petranovi\u0107 Ov\u010dari\u010dek P, Giovanella L, Carri\u00f3 Gasset I, Hindi\u00e9 E, Huellner MW, Luster M, et al. The EANM practice guidelines for parathyroid imaging. Eur J Nucl Med Mol Imaging. 2021;48(9):2801\u201322.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"3768_CR24","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1210\/jc.2012-3168","volume":"98","author":"JW Kunstman","year":"2013","unstructured":"Kunstman JW, Kirsch JD, Mahajan A, Udelsman R. Parathyroid Localization and Implications for Clinical Management. J Clin Endocrinol Metabolism. 2013;98(3):902\u201312.","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"7","key":"3768_CR25","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1002\/hed.25781","volume":"41","author":"M Zafereo","year":"2019","unstructured":"Zafereo M, Yu J, Angelos P, Brumund K, Chuang HH, Goldenberg D, et al. American Head and Neck Society Endocrine Surgery Section update on parathyroid imaging for surgical candidates with primary hyperparathyroidism. Head Neck. 2019;41(7):2398\u2013409.","journal-title":"Head Neck"},{"issue":"3","key":"3768_CR26","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1210\/jc.2012-4022","volume":"98","author":"MW Yeh","year":"2013","unstructured":"Yeh MW, Ituarte PH, Zhou HC, Nishimoto S, Liu IL, Harari A, et al. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab. 2013;98(3):1122\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"3768_CR27","doi-asserted-by":"publisher","first-page":"e401","DOI":"10.1016\/j.crad.2022.02.018","volume":"77","author":"A Zarei","year":"2022","unstructured":"Zarei A, Karthik S, Chowdhury FU, Patel CN, Scarsbrook AF, Vaidyanathan S. Multimodality imaging in primary hyperparathyroidism. Clin Radiol. 2022;77(6):e401\u201316.","journal-title":"Clin Radiol"},{"issue":"1","key":"3768_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s12149-021-01681-w","volume":"36","author":"ET Durmu\u015f","year":"2022","unstructured":"Durmu\u015f ET, Atmaca A, Kefeli M, Mete \u00d6, Canbaz Tosun F, Bay\u00e7elebi D, et al. Clinicopathological variables that correlate with sestamibi positivity in uniglandular parathyroid disease: a retrospective analysis of 378 parathyroid adenomas. Ann Nucl Med. 2022;36(1):33\u201342.","journal-title":"Ann Nucl Med"},{"issue":"5","key":"3768_CR29","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1097\/01.SLA.0000064362.58751.59","volume":"237","author":"RE Goldstein","year":"2003","unstructured":"Goldstein RE, Billheimer D, Martin WH, Richards K. Sestamibi scanning and minimally invasive radioguided parathyroidectomy without intraoperative parathyroid hormone measurement. Ann Surg. 2003;237(5):722\u201330. discussion 30\u2009\u2013\u20091.","journal-title":"Ann Surg"},{"issue":"5","key":"3768_CR30","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/BF03027403","volume":"19","author":"TF Cermik","year":"2005","unstructured":"Cermik TF, Puyan FO, Sezer A, Firat MF, Berkarda S. Relation between Tc-99m sestamibi uptake and biological factors in hyperparathyroidism. Ann Nucl Med. 2005;19(5):387\u201392.","journal-title":"Ann Nucl Med"},{"key":"3768_CR31","doi-asserted-by":"publisher","first-page":"9649564","DOI":"10.1155\/2020\/9649564","volume":"2020","author":"AM Parikh","year":"2020","unstructured":"Parikh AM, Grogan RH, Mor\u00f3n FE. Localization of Parathyroid Disease in Reoperative Patients with Primary Hyperparathyroidism. Int J Endocrinol. 2020;2020:9649564.","journal-title":"Int J Endocrinol"},{"issue":"7","key":"3768_CR32","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/00006231-200307000-00004","volume":"24","author":"H Wakamatsu","year":"2003","unstructured":"Wakamatsu H, Noguchi S, Yamashita H, Yamashita H, Tamura S, Jinnouchi S, et al. Parathyroid scintigraphy with 99mTc-MIBI and 123I subtraction: a comparison with magnetic resonance imaging and ultrasonography. Nucl Med Commun. 2003;24(7):755\u201362.","journal-title":"Nucl Med Commun"},{"issue":"11","key":"3768_CR33","doi-asserted-by":"publisher","first-page":"4900","DOI":"10.1007\/s00330-018-5437-8","volume":"28","author":"R Argir\u00f2","year":"2018","unstructured":"Argir\u00f2 R, Diacinti D, Sacconi B, Iannarelli A, Diacinti D, Cipriani C, et al. Diagnostic accuracy of 3T magnetic resonance imaging in the preoperative localisation of parathyroid adenomas: comparison with ultrasound and 99mTc-sestamibi scans. Eur Radiol. 2018;28(11):4900\u20138.","journal-title":"Eur Radiol"},{"issue":"3","key":"3768_CR34","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.surg.2016.05.003","volume":"160","author":"WP Kluijfhout","year":"2016","unstructured":"Kluijfhout WP, Venkatesh S, Beninato T, Vriens MR, Duh QY, Wilson DM, et al. Performance of magnetic resonance imaging in the evaluation of first-time and reoperative primary hyperparathyroidism. Surgery. 2016;160(3):747\u201354.","journal-title":"Surgery"},{"issue":"1","key":"3768_CR35","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2463\/mrms.mp.2021-0149","volume":"22","author":"H Yamamoto","year":"2023","unstructured":"Yamamoto H, Iima M, Kishimoto Y, Kishimoto AO, Koyasu S, Yamamoto A, et al. Preoperative Localization of Parathyroid Adenomas with Diffusion MR Imaging: Readout-segmented versus Single-shot Echo-planar Imaging. Magn Reson Med Sci. 2023;22(1):79\u201385.","journal-title":"Magn Reson Med Sci"},{"issue":"5","key":"3768_CR36","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s11547-018-0970-8","volume":"124","author":"S Yildiz","year":"2019","unstructured":"Yildiz S, Aralasmak A, Yetis H, Kilicarslan R, Sharifov R, Alkan A, et al. MRI findings and utility of DWI in the evaluation of solid parathyroid lesions. Radiol Med. 2019;124(5):360\u20137.","journal-title":"Radiol Med"},{"issue":"5","key":"3768_CR37","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1177\/0194599815599372","volume":"153","author":"AM Hinson","year":"2015","unstructured":"Hinson AM, Lee DR, Hobbs BA, Fitzgerald RT, Bodenner DL, Stack BC Jr. Preoperative 4D CT Localization of Nonlocalizing Parathyroid Adenomas by Ultrasound and SPECT-CT. Otolaryngol Head Neck Surg. 2015;153(5):775\u20138.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"3768_CR38","doi-asserted-by":"crossref","unstructured":"Tay D, Das JP, Yeh R. Preoperative Localization for Primary Hyperparathyroidism: A Clinical Review. Biomedicines. 2021;9(4):390.","DOI":"10.3390\/biomedicines9040390"},{"issue":"11","key":"3768_CR39","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1002\/lary.27213","volume":"128","author":"K Ibraheem","year":"2018","unstructured":"Ibraheem K, Toraih EA, Haddad AB, Farag M, Randolph GW, Kandil E. Selective parathyroid venous sampling in primary hyperparathyroidism: A systematic review and meta-analysis. Laryngoscope. 2018;128(11):2662\u20137.","journal-title":"Laryngoscope"},{"issue":"1","key":"3768_CR40","first-page":"144","volume":"52","author":"S G\u00fccek Hac\u0131yanl\u0131","year":"2022","unstructured":"G\u00fccek Hac\u0131yanl\u0131 S, Acar N, Ball\u0131 \u00d6, Erdo\u011fan N, Hac\u0131yanl\u0131 M. Selective venous sampling in primary hyperparathyroidism: Is it worth doing? Turk J Med Sci. 2022;52(1):144\u20139.","journal-title":"Turk J Med Sci"},{"issue":"1","key":"3768_CR41","doi-asserted-by":"publisher","first-page":"7058","DOI":"10.1038\/s41598-022-11238-0","volume":"12","author":"J Ho","year":"2022","unstructured":"Ho J, Kim D, Lee JE, Hong N, Kim BM, Kim DJ, et al. Parathyroid venous sampling for the preoperative localisation of parathyroid adenoma in patients with primary hyperparathyroidism. Sci Rep. 2022;12(1):7058.","journal-title":"Sci Rep"},{"issue":"6","key":"3768_CR42","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1007\/s00330-017-5190-4","volume":"28","author":"GF Huber","year":"2018","unstructured":"Huber GF, H\u00fcllner M, Schmid C, Brunner A, Sah B, Vetter D, et al. Benefit of (18)F-fluorocholine PET imaging in parathyroid surgery. Eur Radiol. 2018;28(6):2700\u20137.","journal-title":"Eur Radiol"},{"issue":"10","key":"3768_CR43","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1007\/s00259-018-3980-9","volume":"45","author":"M Beheshti","year":"2018","unstructured":"Beheshti M, Hehenwarter L, Paymani Z, Rendl G, Imamovic L, Rettenbacher R, et al. (18)F-Fluorocholine PET\/CT in the assessment of primary hyperparathyroidism compared with (99m)Tc-MIBI or (99m)Tc-tetrofosmin SPECT\/CT: a prospective dual-centre study in 100 patients. Eur J Nucl Med Mol Imaging. 2018;45(10):1762\u201371.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"3768_CR44","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s11307-018-1179-x","volume":"20","author":"AA Alharbi","year":"2018","unstructured":"Alharbi AA, Alshehri FM, Albatly AA, Sah BR, Schmid C, Huber GF, et al. [(18)F]Fluorocholine Uptake of Parathyroid Adenoma Is Correlated with Parathyroid Hormone Level. Mol Imaging Biol. 2018;20(5):857\u201367.","journal-title":"Mol Imaging Biol"},{"issue":"5","key":"3768_CR45","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00423-009-0534-4","volume":"394","author":"R Mihai","year":"2009","unstructured":"Mihai R, Simon D, Hellman P. Imaging for primary hyperparathyroidism\u2013an evidence-based analysis. Langenbecks Arch Surg. 2009;394(5):765\u201384.","journal-title":"Langenbecks Arch Surg"},{"issue":"1","key":"3768_CR46","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1210\/jc.2007-0600","volume":"93","author":"H Siilin","year":"2008","unstructured":"Siilin H, Rastad J, Ljunggren Os, Lundgren E. Disturbances of Calcium Homeostasis Consistent with Mild Primary Hyperparathyroidism in Premenopausal Women and Associated Morbidity. J Clin Endocrinol Metabolism. 2008;93(1):47\u201353.","journal-title":"J Clin Endocrinol Metabolism"}],"container-title":["BMC Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12893-026-03768-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-026-03768-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-026-03768-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T07:02:59Z","timestamp":1779778979000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12893-026-03768-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3768"],"URL":"https:\/\/doi.org\/10.1186\/s12893-026-03768-5","relation":{},"ISSN":["1471-2482"],"issn-type":[{"value":"1471-2482","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"18 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was conducted in accordance with the Declaration of Helsinki and applicable institutional and national regulations.Ethical approval was not required for this retrospective study in accordance with the institutional and national regulations in place at the time the study was conducted. According to the Ethics Committee of the University Hospital Bonn, submission for ethical review was not mandatory for this type of retrospective analysis. Due to the retrospective and anonymized nature of the study, informed consent to participate was not required in accordance with applicable institutional and national regulations governing retrospective analyses of anonymized clinical data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of clinical data and images was obtained from all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"340"}}